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16.1 INTRODUCTION
Adequate dietary fiber intakes, particularly fiber from cereal grains, have been
associated with a low risk of colorectal cancer (1). Wheat bran appears to protect
against tumor development more consistently than other sources of plant fiber in a
number of experimental colon cancer studies (2–4). Several hypotheses have been
established to explain the link between wheat bran and cancer prevention, including
the increase of overall GI transit time, dilution of carcinogenic compounds, release
of short-chain fatty acids, and promotion of tumor suppressor signaling, among
others (5–8). However, the experimental evidence by using different fiber sources or
different doses on colon cancer prevention is controversial (9,10). Especially, a study
conducted in theTakemoto laboratory showed that antitumor activities ofwheat bran
from various wheat cultivars were significantly different even when fiber content
was equal (11).
Lignans are a group of the phytochemicals that are composed of phenylpropane
dimer linked with a 1,4-diarylbutane structure by b-b bonds. Figure 16.1 shows the
chemical structure of a few prominent lignans. Lignans not only present abundantly in
flaxseed but also present in various grains such as wheat (12). In wheat, lignans are
located in thepericarpandaleurone layerswith thehighest concentration inwheat bran
(13). The main lignan in wheat bran is SDG. Table 16.1 lists the contents of SDG in
flaxseed, wheat bran, and some other selected plant foods.
As one group of secondary metabolites, lignans are synthesized via phenyl-
propanoid pathway. However, the completed biosynthetic pathways to the lignans in
wheat are not clear. The Lewis laboratory from the Washington State University
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reported a series of studies of the lignan biosynthesis inForsythia intermedia (15–17).
As shown in Fig. 16.2, the biosynthetic pathways to secoisolariciresinol occur via
coupling of two coniferyl alcohol molecules to afford pinoresinol. Then pinoresinol
undergoes sequential reduction by pinoresinol–lariciresinol reductase (PLR) to gene-
rate lariciresinol and secoisolariciresinol (15,16). Our ongoing studies are trying to
TABLE 16.1 Level of Lignans in Selected Plant Foods
Food Total lignans, mg/g
Whole flaxseed 636–2213a
Flaxseed meal 675b
Flaxseed flour 527b
Wheat bran 0.5–83a
Oat bran 6.5b
Soy bean 8.6b
aThe contents of lignans in 10 flaxseed samples (unpublished data) and 4 wheat cultivars weremeasured by
HPLC analysis as described in our previous publication (Qu et al. 2005).
bAdapted from Reference (14).
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Figure16.2 Schematic overviewof the lignanbiosynthesis pathway. Pinoresinol–lariciresinol
reductase (PLR) is the last enzyme directly downstream of the biosynthetic pathways from
coniferyl alcohol to secoisolariciresinol (modified from Refrence 16).
Figure 16.1 Chemical structures of the prominent lignans: secoisolariciresinol,
mataisoresinol, and pinoresinol.
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developgenetically engineeredwheat lines that haveoverexpressedPLRand thusmay
potentially generate a high level of SDG.
16.2 LIGNANS AND CANCER PREVENTION
When SDG is consumed, it is oxidized by intestinal microflora to lignan metabolites
including enterodiol and enterolactone (Fig. 16.3). The pharmacokinetics of lignan
metabolites after SDG consumption have been reported (18). Therefore, dietary
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Figure 16.3 Chemicals structures of the secoisolariciresinol diglucoside and its mammalian
metabolites: enterodiol and enterolactone.
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lignans such as SDG may exert their biological effects through their metabolites.
Compelling data from epidemiological, clinical, and experimental studies, alongwith
in vitromechanistic studies, have suggested that lignans may be promising for cancer
prevention.
16.2.1 Epidemiological and Clinical Studies
Although some controversial data exist, many epidemiological studies have suggested
an inverse relationship between lignan consumption and various cancer risks. Adler-
creutzandhis teamin theUniversityofHelsinkihave intensivelystudied the relationship
between plasma or urine levels of lignan metabolites and cancer risk since 1981. They
found that a lignan-lowdietwas related to an increased breast cancer risk in case-control
and prospective studies (19). A review paper summarized a conclusion that the most
support for a cancer preventive role of dietary lignans was observed for premenopausal
breast cancer (20). Furthermore, a case-control study conducted in the Netherlands
recently demonstrated that a substantial reduction of colorectal adenoma risk was
associated with a high plasma level of lignan metabolites (21). Another case-control
study from Sweden further supported a reverse correlation of serum levels of lignan
metabolites with prostate cancer risk (22). However, the conflicting results have been
reported.Acase-control studynestedwithina prospective cohort studyby theNewYork
University Women’s Health Study did not find a protective role of circulating lignan
enterolactone against breast cancer development (23). A prospective Zutphen Elderly
cohort study conducted in the Netherlands did not find an association of a total lignan
intake with cancer risk (24). Arts and Hollman (25) reviewed three prospective nested
case-control studies and three case-control studies and found an inverse association
between lignans, and breast cancer, and observed prostate cancer only in case-control
studies but not in prospective studies. The conflicting data have been suggested, at least
in part, due to inadequate databases used in dietary lignan estimation (26). It is
interesting to note that a clinical intervention study by the Thompson laboratory has
shown a potential reduction of breast cancer growth in patients supplemented with
dietary flaxseed, the richest source of dietary lignans (27).
16.2.2 Experimental Animal Studies
In comparison with epidemiological studies, more consistent results regarding
cancer-preventive role of dietary lignans have been demonstrated in animal models.
For example, dietary flaxseed at 10% or purified SDG at an equivalent dose during
sucking significantly suppressed later 9,10-dimethyl-1,2-benzanthracene-induced
mammary tumorigenesis in rats (28). A study conducted in athymic mice carrying
LNCaP human prostate cancer xenografts showed that dietary lignan 7-hydroxyma-
tairesinol at 0.3% inhibited the tumor growth significantly (29).A similarmodel using
athymic mice but with MCF-7 human breast cancer xenografts demonstrated dietary
flaxseed at 10% attenuated soy protein-stimulated tumor growth (30). Recently, the
Thompson laboratory reported that dietary flaxseed at 10% inhibited metastasis but
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not the recurrence of estrogen receptor negative human breast cancer cells after
excision in nude mice (31).
Wealso conducted an animal study to assess the effects of dietary lignanSDGon
azoxymethane-induced aberrant crypt foci (ACF) formation in rat colons. ACF are
morphologically altered crypts, alone or in cluster, first identified by microscopic
examination of methylene blue-stained whole-mount preparations of colonic mucosa
from azoxymethane-treated rodents (32). Studies demonstrated that ACF in humans
are important precursors to human colon cancer (33). As shown in Table 16.2, we
found that 0.01% SDG significantly reduced the formation of ACF.
16.3 PLAUSIBLE MECHANISMS OF LIGNANS
FOR CANCER PREVENTION
As a group of the phytoestrogens, lignansmay act through estrogen receptor-mediated
mechanisms. Webb andMcCullough (20) have reviewed this potential mechanism in
details. They also discussed a potential interaction of the phytoestrogenic activitywith
other growth hormones as well as antioxidant and antiproliferative activities. In fact,
our previous studies and others have shown that enterolactone is a strong antioxidant
against human LDL oxidation (34,35). We also found that enterolactone was capable
of inhibiting colon cancer cell growth and inducing detoxification enzyme activity
(36,37). Furthermore, the chemopreventive mechanisms of lignans and lignan
metabolites via antiinflammatory and immunosuppressive activities have been inten-
sively reviewed by Saleem et al. (38).
We assessed the cancer preventive mechanisms of two prominent lignan
metabolites on a human colonic cancer cell line SW480. Treatment of SW480 cells
with enterolactone and enterodiol, alone or in combination, at 0–40mM resulted in a
dose- and time-dependent decrease in cell numbers (37). While the cytotoxicity as
measured by tyrpan blue stainingwas not significantly changed,DNAflowcytometric
analysis indicated that treatments induced cell cycle arrest at S phase (Fig. 16.4).
Furthermore, apoptosis analysis by TUNEL assay showed an increased percentage of
apoptotic cells in the treated cells (Fig. 16.5). These results suggest that inhibition of
cancer cell growth by lignan metabolites appears to be mediated with cytostatic and
apoptotic mechanisms.
TABLE 16.2 Inhibition of Azoxymethane (AOM)-induced Formation of Aberrant
Crypt Foci (ACF) in F344 Rats by Dietary Secoisolariciresinol Diglucoside (SDG)
Treatment No. rats with ACF Total no. ACF/colon
Control diet 6/6 264  43
0.01% SDG 6/6 196  51*
Male F344 rats at 6 weeks old were fed either control or experimental diet containing SDG at 0.01% for 4
weeks. One day after the first dietary treatment, rats were given s.c. injection with 15mg/kg B.W. of AOM
once per week for 2 weeks. At the end of 4-week dietary treatment, rats were terminated under ether
euthanasia and the entire colonwas resected for 0.2%methyleneblue staining.ThenumberofACFper colon
was scored under a light microscope. Values are means  SD, *P < 0.05 versus the controls (n= 6).
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Taken together, the observations, direct in vitro cell culture studies along with
in vivo animal experiment, as well as the epidemiological correlation between lignan
intake and antitumor activities, suggest that dietary lignans may attribute to the
observed cancer prevention. However, most studies so far have been performed by
using lignan-rich foods such as flaxseed. We recently conducted a study by
measuring lignan contents in four wheat cultivars (e.g., “Madison,” “Ernie,” “Betty”
and “Arapahoe”) and tried to link them with antitumorigenesis in APCMin mouse
model. APCMin mice carry truncated adenomatous polyposis coli (APC) and thus
spontaneously develop multiple intestinal neoplasia (Min). Drankhan et al. (11)
applied this model into tumor prevention by feeding wheat bran and found a
significant difference in antitumor activity among various wheat cultivars when the
fiber contents were equal. As shown in Table 16.3, we compared the SDG contents in
four wheat cultivars with antitumor activities in APCMin mice and found a signifi-
cant correlation between SDG contents and antitumor activities, suggesting lignans
may attribute to the observed colon cancer prevention by wheat bran or whole grain
products.
Figure 16.4 Induction of cell cycle arrest at S phase by enterolactone, enterodiol, or their
combination. The human colon cancer SW480 cells were cocultured with the indicated lignan
metabolites at 0–40mmol/L for 24–72 h and the cell cycle was measured by DNA flow
cytometric analysis. Values are mean  SD (n¼ 5–6). Means within a treatment without a
common letter differ, P 0.05. (Adapted from Reference 3.).
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